PM Stock Trades at Premium Value: Should You Buy, Hold or Sell?

Philip Morris International (PM) currently trades at a premium forward P/E of 20.93X, notably above its industry and sector averages, despite recent stock underperformance with shares falling 6.4% in the past month and trading below its 50-day moving average. While facing challenges like traditional cigarette volume declines (1.5% in Q2 2025) and ZYN shipment volatility, PM's long-term growth is driven by its smoke-free portfolio, which comprised 41% of Q2 revenues and grew 15.2% organically. The company is also targeting $2 billion in cost efficiencies by 2026 and recently raised its full-year adjusted EPS guidance to $7.43-$7.56, reflecting confidence in sustained double-digit earnings growth, leading to a Zacks 'Hold' recommendation.

Analysis

Philip Morris International (PM) presents a dichotomous investment case, characterized by a premium valuation and strong long-term fundamentals clashing with recent market underperformance and operational headwinds. The stock trades at a forward P/E of 20.93X, significantly above its tobacco industry peer average of 15.31X, yet its shares have declined 6.4% in the past month while peers like Altria and British American Tobacco rallied over 10%. This negative momentum is technically reinforced by the stock trading below its 50-day simple moving average. Key challenges include a 1.5% year-over-year decline in Q2 cigarette shipment volumes, with management projecting a steeper 3-4% drop in the second half due to regulatory issues in Turkey and illicit trade in Indonesia. Furthermore, currency volatility trimmed 4 cents from guided EPS, and shipment volatility for the high-demand ZYN product has reduced near-term visibility. Counterbalancing these concerns is the company's successful smoke-free transformation; this segment now accounts for 41% of total net revenue and grew 15.2% organically in Q2. The legacy combustible business also demonstrates resilience, with pricing power driving a 2.1% increase in net revenues despite volume declines. Management's confidence is underscored by a $2 billion cost-efficiency program and an increased full-year adjusted EPS guidance to $7.43-$7.56, implying robust 13-15% growth, a sentiment echoed by modest upward revisions in analyst consensus estimates.

Key Decisions for Investors

• Investors should weigh the stock's premium valuation and recent underperformance against the company's raised full-year EPS guidance, which projects strong 13-15% earnings growth.
• Closely monitor the revenue growth and shipment consistency of the smoke-free segment, as its ability to offset accelerating volume declines in traditional cigarettes is critical to justifying the current multiple.
• Acknowledge the short-term bearish technical signal of the stock trading below its 50-day moving average and remain cognizant of persistent risks from currency fluctuations and regulatory headwinds in key international markets.
• Given the conflicting signals, a hold strategy may be prudent, waiting for evidence that fundamental growth can overcome the current negative price momentum and justify its premium valuation relative to peers.